![A pink ribbon for Breast Cancer Awareness Month](https://www.uc.edu/news/articles/2023/11/n21208622/jcr:content/image.img.cq5dam.thumbnail.500.500.jpg/1699368645888.jpg)
WCPO: University of Cincinnati Cancer Center survivorship services connect patients to help after treatment
WCPO recently highlighted the University of Cincinnati Cancer Center's Survivorship & Supportive Services Program that connects survivors to the resources they need to thrive.
"It's taught me that I'm truly not alone," breast cancer survivor and program participant Sharen King told WCPO. "I didn't have the time to be afraid, I just knew I had to take care of me. I have nine nieces and nephews, and I'm Auntie."
Elizabeth Shaughnessy, MD, Cancer Center member, adjunct professor, vice chair for patient experience and division director of survivorship in the UC College of Medicine, said there are more than 18 million cancer survivors living in the United States currently, with that number expected to grow to 20 million by 2025.
"It's a lot of people and with that comes a lot of baggage and we need to be able to address those medical problems going forward," Shaughnessy said.
The Survivorship & Supportive Services Program is open to patients at any health system who are in cancer remission and may be facing new challenges. Services include oncology primary care, physical, occupational and music therapy and mental health, fertility, sexual health and sleep resources to help people living with cancer get "back to normal" as much as possible.
Featured photo at top of Breast Cancer Awareness Month ribbon. Photo/Lludmila Chernetska/iStock.
Related Stories
CureToday: UC enrolling patients for glioblastoma trial
March 29, 2022
CureToday highlighted the University of Cincinnati's new glioblastoma immunotherapy trial in a recent article.
Physics World names UC, Cincinnati Children's study among top 10 Breakthroughs of 2022
December 8, 2022
Physics World recognized the University of Cincinnati's first-in-human trial of FLASH radiotherapy as one of the Top 10 Breakthroughs of the Year for 2022.
Local 12: Researcher working to help patients with tough-to-beat pancreatic cancer
February 8, 2023
Local 12 highlighted the University of Cincinnati's Andrew Waters and his research into novel treatments for pancreatic cancer.
Wall Street Journal: More women with breast cancer could skip harsh radiation
February 16, 2023
The University of Cincinnati Cancer Center's Sara Medek and Elizabeth Shaughnessy were featured in a Wall Street Journal article commenting on a recent study that found more older women with low-risk breast cancer could forgo radiation after surgery to avoid further side effects.
Dermatology Times features UC research of nail squamous cell carcinoma treatment
June 9, 2022
Dermatology Times featured recent research by University of Cincinnati researchers that showed a low recurrence rate of nail squamous cell carcinoma when treated with surgical approaches other than amputation.
GEN News: Biomarker discovery to help predict breast cancer outcomes
September 7, 2022
GEN News highlighted recent University of Cincinnati and Cincinnati Children's Hospital Medical Center research on metabolic signatures that help predict breast cancer outcomes and could open avenues for new treatments.
Healio: Sleep, diet among keys to preserving cognitive function during cancer survivorship
September 25, 2023
The University of Cincinnati's Rhonna Shatz, DO, spoke with Healio about cognitive function during cancer survivorship.
Local 12, Business Courier highlight Blood Cancer Healing Center
February 19, 2024
Local 12 and the Cincinnati Business Courier highlighted the University of Cincinnati Cancer Center's Blood Cancer Healing Center, a comprehensive all-in-one facility dedicated solely to advancing research, treatment and wellness for blood cancer patients, opening this summer.
OncLive and Targeted Oncology: Drug yields long-lasting benefits to treat PEComa tumors
March 22, 2024
OncLive and Targeted Oncology covered research presented by the University of Cincinnati's Thomas Herzog that found patients with perivascular epithelioid sarcoma (PEComa) of gynecologic or peritoneal origin experienced rapid, durable responses when treated with the drug nab-sirolimus.
MedPage Today: Promising results for living donor transplants
April 5, 2022
The University of Cincinnati's Shimul Shah, MD, was featured in a MedPage Today article highlighting recent research on the success of living donor transplants for patients with unresectable colorectal cancer liver metastases.